FlowPhysix and 3comma Form Strategic International Alliance
FlowPhysix™ Inc., formerly known as Expanse ICE, has announced its new partnership with 3comma Medical GmbH to distribute the cutting-edge FLOWRUNNER™ Aspiration System. This collaboration represents a major advancement in making superior thrombectomy solutions more accessible to healthcare professionals worldwide.
3comma's Expertise in Medical Device Distribution
3comma operates as a top-tier international commercialization agency, focusing on boosting revenue for emerging companies in the medical device sector. With extensive experience, 3comma is prepared to assist FlowPhysix in setting new benchmarks in thrombectomy technology globally. This will allow FlowPhysix to focus on its commercialization efforts within the United States.
Projecting the Partnership's Impact
This collaboration is expected to make a significant mark on the global thrombectomy market. Marc Paris, Managing Partner at 3comma and former Vice President of International at Penumbra, Inc., remarked, "We can quickly leverage our established infrastructure to expedite the adoption of the FLOURUNNER System. We see FlowPhysix becoming a critical player in this dynamic market."
The FLOWRUNNER™ Aspiration System: Revolutionizing Thrombectomy Technology
The FLOWRUNNER System effectively tackles the vacuum decay issues often faced with traditional aspiration catheters. Through the use of FlowPhysix’s proprietary technology, it provides a highly efficient method for removing clots. The catheter is designed to navigate through a sheath and exit via a distal valve, delivering continuous and effective aspiration force straight to the thrombus.
How the Device Achieves Success
This advanced technology operates by continuously cycling between extending and retracting the aspiration catheter, which shears and evacuates thrombus segments aided by an integrated saline flush. The FLOWRUNNER has proved successful in removing various types of significant thrombi, facilitating the restoration of normal blood flow.
A Vision for the Future of Thrombectomy Care
CEO Jeff Hopkins shared his enthusiasm for the partnership: "Our technology has the capability to transform thrombectomy standards. This alliance enhances our ability to bring our innovative solutions to patients worldwide. We believe that 3comma’s vast expertise will drive our international commercial success while also boosting shareholder value," he noted.
For More Information
To learn more about FlowPhysix and its groundbreaking thrombectomy system, interested parties can check out their official website for additional details on the FLOWRUNNER and its features.
Frequently Asked Questions
What is the FLOWRUNNER™ Aspiration System?
The FLOWRUNNER™ Aspiration System is a state-of-the-art medical device aimed at enhancing the thrombectomy process by efficiently removing clots and restoring blood circulation.
How does the technology work?
This device utilizes a specialized catheter that consistently applies aspiration force, extending and retracting cyclically to effectively shear and evacuate thrombi.
Who is 3comma, and what will their role be?
3comma is a global commercialization agency that will collaborate with FlowPhysix to distribute the FLOWRUNNER system internationally, using their expertise to drive market adoption.
What impact will this partnership have on healthcare providers?
The goal of this partnership is to enhance access to advanced thrombectomy technologies for healthcare professionals outside the United States, ultimately improving patient outcomes.
What does FlowPhysix envision for the future?
FlowPhysix aims to redefine current thrombectomy care standards while broadening their reach and enhancing shareholder value through strategic collaborations.
